{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:54:31Z","timestamp":1787748871430,"version":"build-2784847793"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1093\/qjmed\/hcy102","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T03:11:07Z","timestamp":1526440267000},"page":"531-539","source":"Crossref","is-referenced-by-count":19,"title":["Visual analogue scales for interstitial lung disease: a prospective validation study"],"prefix":"10.1093","volume":"111","author":[{"given":"H","family":"Yates","sequence":"first","affiliation":[{"name":"Respiratory and Sleep Physiology, Royal Brompton and Harefield NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H I","family":"Adamali","sequence":"additional","affiliation":[{"name":"Bristol ILD Service, North Bristol NHS Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Maskell","sequence":"additional","affiliation":[{"name":"Academic Respiratory Unit, University of Bristol, Southmead Hospital, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Barratt","sequence":"additional","affiliation":[{"name":"Bristol ILD Service, North Bristol NHS Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Sharp","sequence":"additional","affiliation":[{"name":"Respiratory Department, Gloucestershire Hospitals NHS Foundation Trust, Gloucester Royal Hospital, Great Western Road, Gloucester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"key":"key\n\t\t\t\t20180803040002_hcy102-B1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/thoraxjnl-2012-201581","article-title":"The development and validation of the King\u2019s Brief Interstitial Lung Disease (K-BILD) health status questionnaire","volume":"67","author":"Patel","year":"2012","journal-title":"Thorax"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B2","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1164\/rccm.201504-0768UP","article-title":"Update in interstitial lung disease 2014","volume":"192","author":"Belloli","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","article-title":"Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B4","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/thoraxjnl-2012-202040","article-title":"Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature","volume":"68","author":"Bajwah","year":"2013","journal-title":"Thorax"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B5","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/resp.12649","article-title":"Symptom-based management of the idiopathic interstitial pneumonia","volume":"21","author":"Garibaldi","year":"2016","journal-title":"Respirol Carlton Vic"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1553-2712.2000.tb02231.x","article-title":"Clinically meaningful changes in quantitative measures of asthma severity","volume":"7","author":"Karras","year":"2000","journal-title":"Acad Emerg Med off J Soc Acad Emerg Med"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B7","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1378\/chest.121.4.1092","article-title":"Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD","volume":"121","author":"de Torres","year":"2002","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B8","doi-asserted-by":"crossref","first-page":"e0123798.","DOI":"10.1371\/journal.pone.0123798","article-title":"Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions","volume":"10","author":"Mishra","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B9","first-page":"479","article-title":"Validation of a visual analog scale to measure dyspnea in patients with diffuse interstitial lung disease","volume":"46","author":"Ram\u00edrez-Venegas","year":"1994","journal-title":"Rev Investig Cl\u00ednica Organo Hosp Enfermedades Nutr"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B10","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archinte.1993.00410110045008","article-title":"Assessing the clinical importance of symptomatic improvements. An illustration in rheumatology","volume":"153","author":"Redelmeier","year":"1993","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status. Ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control Clin Trials"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1081\/COPD-200050655","article-title":"Minimally clinically important difference for the UCSD shortness of breath questionnaire, borg scale, and visual analog scale","volume":"2","author":"Ries","year":"2005","journal-title":"COPD J Chronic Obstr Pulm Dis"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B14","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0895-4356(89)90105-4","article-title":"Should study subjects see their previous responses: data from a randomized control trial","volume":"42","author":"Guyatt","year":"1989","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes","volume":"61","author":"Revicki","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B16","doi-asserted-by":"crossref","first-page":"4.","DOI":"10.1186\/2213-0802-2-4","article-title":"Diagnosis and management of interstitial lung disease","volume":"2","author":"Meyer","year":"2014","journal-title":"Transl Respir Med"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B17","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1164\/rccm.201105-0840OC","article-title":"Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference","volume":"184","author":"du Bois","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1183\/09059180.00001711","article-title":"Challenges in idiopathic pulmonary fibrosis trials: the point on end-points","volume":"20","author":"Albera","year":"2011","journal-title":"Eur Respir Rev"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1527-5299.2004.03475.x","article-title":"Measuring the dyspnea of decompensated heart failure with a visual analog scale: how much improvement is meaningful?","volume":"10","author":"Ander","year":"2004","journal-title":"Congest Heart Fail Greenwich Conn"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B20","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.rmed.2013.06.009","article-title":"The minimal important difference of the King\u2019s Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease","volume":"107","author":"Patel","year":"2013","journal-title":"Respir Med"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1081\/BIP-120028507","article-title":"Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials","volume":"14","author":"Sloan","year":"2004","journal-title":"J Biopharm Stat"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B22","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jclinepi.2005.07.008","article-title":"Minimally important differences were estimated for the functional assessment of cancer therapy\u2013colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches","volume":"58","author":"Yost","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B23","volume-title":"Computer Software","author":"Minitab 17 Statistical Software","year":"2010"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B24","first-page":"400","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988","edition":"2nd edn"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B25","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/sim.4780110811","article-title":"Sixteen S-squared over D-squared: a relation for crude sample size estimates","volume":"11","author":"Lehr","year":"1992","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B26","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/cphy.c110015","article-title":"Factors limiting exercise tolerance in chronic lung diseases","volume":"2","author":"Vogiatzis","year":"2012","journal-title":"Compr Physiol"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B27","doi-asserted-by":"crossref","first-page":"634761.","DOI":"10.1155\/2012\/634761","article-title":"Mechanisms of physical activity limitation in chronic lung diseases","volume":"2012","author":"Vogiatzis","year":"2012","journal-title":"Pulm Med"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B28","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.rmed.2012.06.018","article-title":"The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis","volume":"106","author":"Swigris","year":"2012","journal-title":"Respir Med"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B29","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/resp.12348","article-title":"Respiratory disease and respiratory physiology: putting lung function into perspective interstitial lung disease","volume":"19","author":"Berend","year":"2014","journal-title":"Respirol Carlton Vic"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B30","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B31","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B32","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1378\/chest.116.5.1175","article-title":"Assessment of health-related quality of life in patients with interstitial lung disease","volume":"116","author":"Chang","year":"1999","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B33","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.rmed.2010.03.027","article-title":"Assessing dyspnea and its impact on patients with connective tissue disease-related interstitial lung disease","volume":"104","author":"Swigris","year":"2010","journal-title":"Respir Med"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B34","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/art.20787","article-title":"Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the scleroderma lung study","volume":"52","author":"Khanna","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B35","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s00520-006-0085-y","article-title":"The clinical significance of quality of life assessments in oncology: a summary for clinicians","volume":"14","author":"Sloan","year":"2006","journal-title":"Support Care Cancer"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B36","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1378\/chest.116.5.1208","article-title":"A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise","volume":"116","author":"Grant","year":"1999","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B37","first-page":"130","article-title":"Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases","volume":"33","author":"Atkins","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis off J WASOG"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1348\/1359107041557048","article-title":"Measuring fatigue in sarcoidosis: the fatigue assessment scale (FAS)","volume":"9","author":"De Vries","year":"2004","journal-title":"Br J Health Psychol"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/msc.163","article-title":"Self-reported outcomes during treatment with tumour necrosis factor alpha inhibitors in patients with rheumatoid arthritis","volume":"8","author":"Bala","year":"2010","journal-title":"Musculoskeletal Care"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1524-4733.2008.00426.x","article-title":"Development of a new questionnaire to assess patient perceptions of cancer-related fatigue: item generation and item reduction","volume":"12","author":"Bar\u00f3","year":"2009","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0165-1781(91)90027-M","article-title":"Validity and reliability of a scale to assess fatigue","volume":"36","author":"Lee","year":"1991","journal-title":"Psychiatry Res"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2466\/PMS.99.5.235-246","article-title":"Visual analogue scale correlates of musculoskeletal fatigue","volume":"99","author":"Leung","year":"2004","journal-title":"Percept Mot Skills"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1745-9974-6-4","article-title":"Objective cough frequency in Idiopathic Pulmonary Fibrosis","volume":"6","author":"Key","year":"2010","journal-title":"Cough Lond Engl"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ppul.10174","article-title":"Objective monitoring of cough in children with cystic fibrosis","volume":"34","author":"Hamutcu","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B45","first-page":"161","article-title":"Validated methods of cough assessment: a systematic review of the literature","volume":"81","author":"Leconte","year":"2011","journal-title":"Respir Int Rev Thorac Dis"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pupt.2016.08.001","article-title":"Antitussive effect of carcainium chloride in patients with chronic cough and idiopathic interstitial pneumonias: a pilot study","volume":"40","author":"Lavorini","year":"2016","journal-title":"Pulm Pharmacol Ther"},{"key":"key\n\t\t\t\t20180803040002_hcy102-B47","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/thoraxjnl-2013-204202","article-title":"Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials","volume":"69","author":"Saketkoo","year":"2014","journal-title":"Thorax"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/qjmed\/article-pdf\/111\/8\/531\/25415610\/hcy102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T19:08:05Z","timestamp":1661281685000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/111\/8\/531\/4996822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,5,16]]},"published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcy102","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2018,5,16]]}}}